Oppenheimer Asset Management’s Elanco Animal Health ELAN Stock Holding History

Oppenheimer Asset Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-26,912	Closed	-$326K	–	1146
2024 Q4	$326K	Sell	26,912 -6,281	-19%	-$82.2K	﹤0.01%	962
2024 Q3	$488K	Buy	33,193 +14,902	+81%	+$208K	0.01%	887
2024 Q2	$264K	Buy	18,291 +6,191	+51%	+$98.9K	﹤0.01%	1014
2024 Q1	$197K	Buy	+12,100	New	+$189K	﹤0.01%	1041
2020 Q2	–	Sell	-29,296	Closed	-$656K	–	1168
2020 Q1	$656K	Buy	29,296 +19,673	+204%	+$539K	0.02%	664
2019 Q4	$283K	Sell	9,623 -658	-6%	-$17.9K	0.01%	973
2019 Q3	$274K	Buy	10,281 +156	+2%	+$4.68K	0.01%	971
2019 Q2	$342K	Sell	10,125 -19	-0.2%	-$617	0.01%	923
2019 Q1	$326K	Buy	10,144 +3,360	+50%	+$103K	0.01%	917
2018 Q4	$214K	Buy	+6,784	New	+$222K	0.01%	989

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Oppenheimer Asset Management's ELAN Position: Q1 2025 in Review

Oppenheimer Asset Management sold out of Elanco Animal Health (ELAN) in Q1 2025, closing a stake of 26,912 shares — an estimated $326K sold.

Oppenheimer Asset Management first reported a position in ELAN in Q4 2018 and held it in 10 quarters. The position peaked at $656K in Q1 2020. 365 funds tracked by Wall St. Rank hold ELAN as of Q1 2025.

Oppenheimer Asset Management reported no remaining Elanco Animal Health position as of Q1 2025 after selling out during the quarter.
Oppenheimer Asset Management sold 26,912 Elanco Animal Health shares in Q1 2025, an estimated $326K.
Oppenheimer Asset Management first reported a position in Elanco Animal Health in Q4 2018 and held it in 10 quarters.
Oppenheimer Asset Management's Elanco Animal Health position peaked at $656K in Q1 2020.
365 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2025.

Based on Oppenheimer Asset Management's 13F filing for Q1 2025, filed 23 Apr 2025.